Displaying 25 - 36 of 84
Immune-Mediated and Cholestatic Diseases
6

Intercept: Providing Better Care in PBC – understanding the evolving evidence - ILC 2021

View
Immune-Mediated and Cholestatic Diseases
6

Intercept: Providing Better Care in PBC – understanding the evolving evidence - ILC 2021

View
Immune-Mediated and Cholestatic Diseases
6

Intercept: Providing Better Care in PBC – understanding the evolving evidence - ILC 2021

View
Immune-Mediated and Cholestatic Diseases
6

Intercept: Providing Better Care in PBC – understanding the evolving evidence - ILC 2021

View
Immune-Mediated and Cholestatic Diseases
6

Intercept: Providing Better Care in PBC – understanding the evolving evidence - ILC 2021

View
Viral Hepatitis
2

GSK: HBsAg clearance in chronic hepatitis B: How close is it? - ILC 2021

View
Viral Hepatitis
2

GSK: HBsAg clearance in chronic hepatitis B: How close is it? - ILC 2021

View
Cirrhosis & Complications
5

Grifols: Management of decompensated cirrhotic patient: is it time to look beyond? - ILC 2021

View
Cirrhosis & Complications
5

Grifols: Management of decompensated cirrhotic patient: is it time to look beyond? - ILC 2021

View
Cirrhosis & Complications
5

Grifols: Management of decompensated cirrhotic patient: is it time to look beyond? - ILC 2021

View
Cirrhosis & Complications
5

Grifols: Management of decompensated cirrhotic patient: is it time to look beyond? - ILC 2021

View
Cirrhosis & Complications
5

Grifols: Management of decompensated cirrhotic patient: is it time to look beyond? - ILC 2021

View
Displaying 25 - 36 of 84